Principal Investigators: Jef Boeke, PhD
Neochromosome enables biological engineering at a genome-scale by providing groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct otherwise unapproachable scientific research. The company’s first-in-class capabilities were developed to design, build, and test the world’s first fully synthetic eukaryotic cells. Today, Neochromosome offers its services and platform to researchers and organizations around the world, which includes highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes. This makes Neochromosome uniquely suited to accelerate work in biological engineering.